All systems operational
Q2 2019

Surgery for autoimmune aortitis: unanswered questions

Amr A. Arafat
10.1186/s43057-019-0008-6 378 Views 1 Citations
1
Citations
378
Views
Abstract

AbstractBackgroundThe aorta is rarely affected by autoimmune vasculitis, which can lead to aortic dilatation requiring surgery. Autoimmune aortitis may affect one aortic segment or the entire aorta, and in some cases, the aorta may be affected at different time intervals. Because of the rarity of the disease and the limited cases described in the literature, management of autoimmune aortitis is still controversial. We aimed to review the current literature evidence regarding these controversial aspects for the management of autoimmune aortitis and give recommendations based on this evidence.Main textImmunosuppressants are generally indicated in vasculitis to halt the progression of the disease; however, its role after the occurrence of aortic dilatation is debatable since further aortic dilatation would eventually occur because of the weakness of the arterial wall. In patients with a localized ascending aortic dilatation who required surgery, the optimal approach for the distal aorta is not known. If the probability of disease progression is high, it is not known whether the patients would benefit from postoperative immunosuppressants or further distal aortic intervention may be required. The risk of rupture of the weakened aortic wall was not established, and it is debatable at which diameter should these patients have surgery. In patients with previous ascending surgery for autoimmune aortitis, the endovascular management of the distal aortic disease has not been studied. The inflammatory process may extend to affect the aortic valve or the coronary vessels, which may require special attention during the procedure.ConclusionPatients with diagnosed autoimmune aortitis are prone to the development of the distal aortic disease, and endovascular intervention is feasible in those patients. Patients with concomitant aortic valve can be managed with the aortic valve-sparing procedure, and preoperative screening for coronary disease is recommended. Immunosuppressants should be used early before aortic dilatation, and its role postoperatively is controversial.

Cite this Article (APA)
Amr, A. A. (2019). Surgery for autoimmune aortitis: unanswered questions. The Cardiothoracic Surgeon. https://doi.org/10.1186/s43057-019-0008-6
Related Papers
Requirement of artificial intelligence technology awareness for thoracic surgeons
Anshuman Darbari; Krishan Kumar; Shubhankar Darbari; Prashant L. Patil · 2021
26
cites
386
Requirement of artificial intelligence technology awareness for thoracic surgeons
Anshuman Darbari; Krishan Kumar; Shubhankar Darbari; Prashant L. Patil · 2021
26
cites
388
Cardiac myxomas: a review of current treatment approaches and emerging molecular therapies
Patrick Ashinze; Suvam Banerjee; Emmanuel Egbunu; Wuraola Salawu; Abdullaah Idri · 2024
18
cites
386
Cardiac myxomas: a review of current treatment approaches and emerging molecular therapies
Patrick Ashinze; Suvam Banerjee; Emmanuel Egbunu; Wuraola Salawu; Abdullaah Idri · 2024
18
cites
391
Recent advancements in pediatric cardiopulmonary bypass technology for better outcomes of pediatric …
Yasir Saleem; Anshuman Darbari; Rahul Sharma; Amit Vashisth; Anish Gupta · 2022
16
cites
389
Access
View Full Text via DOI
Published in
ISSN 2662-2203
Quartile Q2
AMS Score 72
Field Medicine & Health Sciences
Publisher Springer (Biomed Central Ltd.)
Country 🇪🇬 Egypt
View Journal Profile →
Authors
Publication Details
Year 2019
Language English
Added 24 Aug 2026